ArticleJournal of health economics and outcomes research2022

Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review.

Karen S Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.